Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Academy, Adare, admitted, alloreactive, Alloy, Analyst, anticancer, appointee, Arcellx, Arix, Arjay, Arlington, Arsenal, assay, AstraZeneca, bachelor, Baltimore, Barrett, barrier, Bay, Beam, Berkeley, Bhavnagri, biochemistry, Biogen, Biology, Biomet, Bioscience, Biovia, blank, Bonderman, BorgWarner, Bren, Bristol, Brown, buildout, built, caltech, Capricor, Carol, Carvykti, Centre, charitable, checkpoint, Cheng, Chicago, Chugai, Citigroup, Claudin, companion, concept, confined, Continental, Cooley, Cornell, Council, Cromwell, cum, Dagger, Dana, Dartmouth, DCR, Deborah, deceptive, Denali, Desert, DeYoung, Diageo, Diamond, disputed, DoR, Doumani, Ducati, Eagle, editorial, Edythe, elevated, Eli, Elizabeth, England, Entrepreneurial, enzyme, epidemic, Eric, ESG, Evozyne, Exactech, extract, faculty, Farber, Fenwal, Flower, Flying, Fontainebleau, Forge, Forstmann, Foundation, founder, Franz, Fremont, gastric, Geffen, Genentech, Genitourinary, geopolitical, Germany, Ginkgo, Glaxo, graduate, graduated, Grassroot, Hadassah, haemophagocytic, Harvard, Healthscope, Hebrew, Hill, honor, Howard, Hubble, Humer, IconOVir, Immucor, immunology, Importantly, IMS, Ingrained, Innsbruck, INSEAD, insight, intolerant, IQVIA, IRA, IVD, Jannsen, Japan, Jelmyto, Jerusalem, John, Joshua, Kazam, KPMG, lattice, laude, liver, magna, Manchester, Maryland, mathematical, Mayo, MBA, Merck, Merkin, Messemer, mg, Michigan, microbiology, military, Miller, misrepresentative, Missing, MIT, Motor, nearby, Neogene, nirogascestat, Northwest, Oak, outpace, Owen, Oxford, Pace, pancreatic, Paradyne, Park, PayPal, Pennsylvania, Pharmacology, Platinum, played, Plough, postdoctoral, PRC, predecessor, presidential, principle, professor, Provost, purported, Radcliffe, RCC, Relmada, residency, resign, resurgence, retaliatory, Roy, Russia, RyanAir, Sarepta, Sato, Saxon, Schering, Schmidt, Scholar, Screaming, Seagate, selexinor, Sheldon, shortage, Showcase, shrinkage, Sisitsky, Soaring, Soccer, spearheaded, spent, Speyer, Stanford, Stephen, strain, succeeded, Sullivan, summa, Sydney, Tech, tenet, Tishman, Todd, tract, trend, TS, UBS, UC, UCLA, Ukraine, unamortized, unconfirmed, undergraduate, underwater, Univision, UroGen, Urologic, Urology, urothelial, Veer, Vertex, Vicki, Vida, vigorously, Vir, Vision, Visiting, Washington, Weizmann, Wharton, wiretapping, WISeKey, witnessing, Witte, Zachary
Filing tables
Filing exhibits
Associated ALLO transcripts
ALLO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statements (Forms S-8 Nos. 333-227965, 333-230164, 333-236701, 333-253530 and 333-262923) pertaining to the Amended and Restated 2018 Equity Incentive Plan and 2018 Employee Stock Purchase Plan of Allogene Therapeutics, Inc., and
(2)Registration Statement (Form S-3 No. 333-268117) of Allogene Therapeutics, Inc.;
of our reports dated February 28, 2023, with respect to the consolidated financial statements of Allogene Therapeutics, Inc. and the effectiveness of internal control over financial reporting of Allogene Therapeutics, Inc. included in this Annual Report (Form 10-K) of Allogene Therapeutics, Inc. for the year ended December 31, 2022.
/s/ Ernst & Young LLP
San Mateo, California
February 28, 2023